Pharmaceutical Technology on MSN
UK approves Gilead’s twice-yearly HIV PrEP drug
Gilead Sciences’ pre-exposure prophylaxis (PrEP) formula of lenacapavir has been approved in the UK as a preventative option ...
According to the latest estimates, more than 100 AIDS cases are now being reported in Kerala every month.
Advancements in HIV/AIDS research, drug development and clinical practice since the 1980s have made it possible for people ...
Gilead Sciences said on Monday its experimental HIV treatment was found to be statistically non-inferior to its top-selling ...
Author Marion Winik's 1996 memoir was reissued as an audiobook read by the author on Dec. 9 with a new print edition to ...
Common HIV and cancer medications damage brain cell functions (lipid imbalance), contributing to cognitive decline. Need for ...
In a person living with HIV, proviruses—strands of HIV DNA—are typically integrated into the T cell genome and become a ...
Coalition of charities and MPs have signed a letter from Geordie Greig, editor-in-chief of The Independent, appealing to the ...
A daily preventive pill can be invaluable for people at risk for HIV. But some doctors don't know much about prescribing them. And billing headaches are common. Here's how to overcome those hurdles.
Local organizations like C.O.P.E. are expanding community-based testing and education efforts in Paterson and North Jersey to ...
An estimated 40.8 million people worldwide are living with HIV, and it killed about 630,000 people last year. Every year since 1988, a global cadre of scientists, doctors, families, and advocates have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results